Written Question·Department of Health and Social Care·UIN 109127

Prostate Cancer: Abiraterone

Tabled: 28 January 2026

Answered: 3 February 2026

Question

Wendy Morton

To ask the Secretary of State for Health and Social Care, with reference to HCWS1248, how many patients with non-metastatic prostate cancer are expected to be eligible for abiraterone in each of the next three financial years; what clinical criteria deter

Answer

Dr Zubir Ahmed

Approximately 2,000 men diagnosed in the last three months with non‑metastatic prostate cancer will now be able to receive abiraterone where it is of clinical benefit, alongside prednisolone. An additional 7,000 men are expected to be diagnosed with prost...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 109127) →